Literature DB >> 33291222

Extracellular Cystatin F Is Internalised by Cytotoxic T Lymphocytes and Decreases Their Cytotoxicity.

Mateja Prunk1, Milica Perišić Nanut1, Tanja Jakoš2, Jerica Sabotič1, Urban Švajger3, Janko Kos1,2.   

Abstract

Cystatin F is a protein inhibitor of cysteine cathepsins, peptidases involved in the activation of the effector molecules of the perforin/granzyme pathway. Cystatin F was previously shown to regulate natural killer cell cytotoxicity. Here, we show that extracellular cystatin F has a role in regulating the killing efficiency of cytotoxic T lymphocytes (CTLs). Extracellular cystatin F was internalised into TALL-104 cells, a cytotoxic T cell line, and decreased their cathepsin C and H activity. Correspondingly, granzyme A and B activity was also decreased and, most importantly, the killing efficiency of TALL-104 cells as well as primary human CTLs was reduced. The N-terminally truncated form of cystatin F, which can directly inhibit cathepsin C (unlike the full-length form), was more effective than the full-length inhibitor. Furthermore, cystatin F decreased cathepsin L activity, which, however, did not affect perforin processing. Cystatin F derived from K-562 target cells could also decrease the cytotoxicity of TALL-104 cells. These results clearly show that, by inhibiting cysteine cathepsin proteolytic activity, extracellular cystatin F can decrease the cytotoxicity of CTLs and thus compromise their function.

Entities:  

Keywords:  TALL-104; cathepsins; cystatin F; cytotoxic lymphocytes; granzymes; perforin

Year:  2020        PMID: 33291222      PMCID: PMC7762138          DOI: 10.3390/cancers12123660

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  26 in total

Review 1.  How Do Cytotoxic Lymphocytes Kill Cancer Cells?

Authors:  Luis Martínez-Lostao; Alberto Anel; Julián Pardo
Journal:  Clin Cancer Res       Date:  2015-11-15       Impact factor: 12.531

Review 2.  Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy.

Authors:  Kawaljit Kaur; Milica Perišić Nanut; Meng-Wei Ko; Tahmineh Safaie; Janko Kos; Anahid Jewett
Journal:  Curr Opin Immunol       Date:  2018-04-10       Impact factor: 7.486

3.  Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera.

Authors:  A Schweiger; B Stabuc; T Popovíc; V Turk; J Kos
Journal:  J Immunol Methods       Date:  1997-02-28       Impact factor: 2.303

4.  Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L.

Authors:  Spela Konjar; Vivien R Sutton; Sabine Hoves; Urška Repnik; Hideo Yagita; Thomas Reinheckel; Christoph Peters; Vito Turk; Boris Turk; Joseph A Trapani; Nataša Kopitar-Jerala
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

5.  Inhibitory properties of cystatin F and its localization in U937 promonocyte cells.

Authors:  Tomaz Langerholc; Valentina Zavasnik-Bergant; Boris Turk; Vito Turk; Magnus Abrahamson; Janko Kos
Journal:  FEBS J       Date:  2005-03       Impact factor: 5.542

Review 6.  NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis.

Authors:  Anahid Jewett; Janko Kos; Yuman Fong; Meng-Wei Ko; Tahmineh Safaei; Milica Perišić Nanut; Kawaljit Kaur
Journal:  Semin Cancer Biol       Date:  2018-08-03       Impact factor: 15.707

7.  Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.

Authors:  J Kos; B Stabuc; A Schweiger; M Krasovec; N Cimerman; N Kopitar-Jerala; I Vrhovec
Journal:  Clin Cancer Res       Date:  1997-10       Impact factor: 12.531

8.  Increased cystatin F levels correlate with decreased cytotoxicity of cytotoxic T cells.

Authors:  Mateja Prunk; Milica Perisic Nanut; Jerica Sabotic; Urban Svajger; Janko Kos
Journal:  Radiol Oncol       Date:  2019-03-03       Impact factor: 2.991

9.  Glycosylation directs targeting and activation of cystatin f from intracellular and extracellular sources.

Authors:  Jeff D Colbert; Anna Plechanovová; Colin Watts
Journal:  Traffic       Date:  2009-01-24       Impact factor: 6.215

10.  Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis.

Authors:  Vivien R Sutton; Nigel J Waterhouse; Kylie A Browne; Karin Sedelies; Annette Ciccone; Desiree Anthony; Aulikki Koskinen; Arno Mullbacher; Joseph A Trapani
Journal:  J Cell Biol       Date:  2007-02-05       Impact factor: 10.539

View more
  5 in total

Review 1.  Lysosomes and lysosome-related organelles in immune responses.

Authors:  Colin Watts
Journal:  FEBS Open Bio       Date:  2022-03-29       Impact factor: 2.792

2.  New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity.

Authors:  Ana Mitrović; Emanuela Senjor; Marko Jukić; Lara Bolčina; Mateja Prunk; Matic Proj; Milica Perišić Nanut; Stanislav Gobec; Janko Kos
Journal:  Comput Struct Biotechnol J       Date:  2022-08-28       Impact factor: 6.155

Review 3.  Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.

Authors:  Anamarija Habič; Metka Novak; Bernarda Majc; Tamara Lah Turnšek; Barbara Breznik
Journal:  J Histochem Cytochem       Date:  2021-07-26       Impact factor: 2.479

Review 4.  The Role of Cysteine Peptidases in Hematopoietic Stem Cell Differentiation and Modulation of Immune System Function.

Authors:  Milica Perišić Nanut; Urša Pečar Fonović; Tanja Jakoš; Janko Kos
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561

Review 5.  Lysosomal peptidases-intriguing roles in cancer progression and neurodegeneration.

Authors:  Janko Kos; Ana Mitrović; Milica Perišić Nanut; Anja Pišlar
Journal:  FEBS Open Bio       Date:  2022-02-03       Impact factor: 2.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.